Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.
Orozco-Moreno M, Visser EA, Hodgson K, Hipgrave Ederveen AL, Bastian K, Goode EA, Öztürk Ö, Pijnenborg JFA, Eerden N, Moons SJ, Rossing E, Wang N, de Haan N, Büll C, Boltje TJ, Munkley J.
Orozco-Moreno M, et al. Among authors: munkley j.
Glycobiology. 2023 Dec 30;33(12):1155-1171. doi: 10.1093/glycob/cwad085.
Glycobiology. 2023.
PMID: 37847613
Free PMC article.